Background Up-to-date evidence about levels and trends in disease and injury incidence,
prevalence, and years lived with disability (YLDs) is an essential input into global, regional, …

Background Non-fatal outcomes of disease and injury increasingly detract from the ability of
the world's population to live in full health, a trend largely attributable to an epidemiological …

Background As mortality rates decline, life expectancy increases, and populations age, non-fatal
outcomes of diseases and injuries are becoming a larger component of the global …

Background The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides
an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden …

Background Improving survival and extending the longevity of life for all populations requires
timely, robust evidence on local mortality levels and trends. The Global Burden of Disease …

Background Waning of vaccine protection against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern. The …

Efficacy of the BNT162b2 mRNA Vaccine in Qatar As of March 31, 2021, more than 265,000
people in Qatar had received both doses of the BNT162b2 vaccine. Viral sequencing …

Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together
all available epidemiological data using a coherent measurement framework, standardised …

Background The protection conferred by natural immunity, vaccination, and both against
symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with the …

Background Measurement of changes in health across locations is useful to compare and
contrast changing epidemiological patterns against health system performance and identify …